Cityland Development Statistics

Total Valuation

PSE:CDC has a market cap or net worth of PHP 2.98 billion. The enterprise value is 3.18 billion.

Market Cap	2.98B
Enterprise Value	3.18B

Important Dates

The last earnings date was Wednesday, April 16, 2025.

Earnings Date	Apr 16, 2025
Ex-Dividend Date	Jun 20, 2024

Share Statistics

PSE:CDC has 4.97 billion shares outstanding.

Current Share Class	n/a
Shares Outstanding	4.97B
Shares Change (YoY)	n/a
Shares Change (QoQ)	+3.59%
Owned by Insiders (%)	18.87%
Owned by Institutions (%)	0.13%
Float	1.36B

Valuation Ratios

The trailing PE ratio is 3.81.

PE Ratio	3.81
Forward PE	n/a
PS Ratio	1.29
PB Ratio	0.24
P/TBV Ratio	0.28
P/FCF Ratio	6.11
P/OCF Ratio	6.09
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.44, with an EV/FCF ratio of 6.50.

EV / Earnings	4.06
EV / Sales	1.37
EV / EBITDA	3.44
EV / EBIT	3.67
EV / FCF	6.50

Financial Position

The company has a current ratio of 4.66, with a Debt / Equity ratio of 0.11.

Current Ratio	4.66
Quick Ratio	1.69
Debt / Equity	0.11
Debt / EBITDA	1.47
Debt / FCF	2.78
Interest Coverage	-87.72

Financial Efficiency

Return on equity (ROE) is 7.05% and return on invested capital (ROIC) is 4.09%.

Return on Equity (ROE)	7.05%
Return on Assets (ROA)	3.75%
Return on Invested Capital (ROIC)	4.09%
Return on Capital Employed (ROCE)	6.72%
Revenue Per Employee	13.11M
Profits Per Employee	4.42M
Employee Count	175
Asset Turnover	0.16
Inventory Turnover	0.14

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -12.68% in the last 52 weeks. The beta is 0.03, so PSE:CDC's price volatility has been lower than the market average.

Beta (5Y)	0.03
52-Week Price Change	-12.68%
50-Day Moving Average	0.63
200-Day Moving Average	0.67
Relative Strength Index (RSI)	44.13
Average Volume (20 Days)	87,250

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PSE:CDC had revenue of PHP 2.32 billion and earned 783.14 million in profits. Earnings per share was 0.16.

Revenue	2.32B
Gross Profit	1.56B
Operating Income	865.84M
Pretax Income	1.08B
Net Income	783.14M
EBITDA	920.30M
EBIT	865.84M
Earnings Per Share (EPS)	0.16

Full Income Statement

Balance Sheet

The company has 2.68 billion in cash and 1.36 billion in debt, giving a net cash position of 1.32 billion or 0.26 per share.

Cash & Cash Equivalents	2.68B
Total Debt	1.36B
Net Cash	1.32B
Net Cash Per Share	0.26
Equity (Book Value)	12.27B
Book Value Per Share	2.16
Working Capital	7.71B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 489.84 million and capital expenditures -1.10 million, giving a free cash flow of 488.74 million.

Operating Cash Flow	489.84M
Capital Expenditures	-1.10M
Free Cash Flow	488.74M
FCF Per Share	0.10

Full Cash Flow Statement

Margins

Gross margin is 67.11%, with operating and profit margins of 37.31% and 33.75%.

Gross Margin	67.11%
Operating Margin	37.31%
Pretax Margin	46.75%
Profit Margin	33.75%
EBITDA Margin	39.66%
EBIT Margin	37.31%
FCF Margin	21.06%

Dividends & Yields

This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 7.69%.

Dividend Per Share	0.05
Dividend Yield	7.69%
Dividend Growth (YoY)	65.74%
Years of Dividend Growth	3
Payout Ratio	33.57%
Buyback Yield	n/a
Shareholder Yield	7.69%
Earnings Yield	26.24%
FCF Yield	16.38%

Dividend Details

Stock Splits

The last stock split was on July 3, 2023. It was a forward split with a ratio of 1.025.

Last Split Date	Jul 3, 2023
Split Type	Forward
Split Ratio	1.025

Scores

PSE:CDC has an Altman Z-Score of 2.27. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.27
Piotroski F-Score	n/a